Aortic Waveform Analysis to Individualize Treatment in Heart Failure

Area of Science:

• Cardiology
• Vascular Physiology
• Pharmacology

Background:

• Afterload reduction is key in managing heart failure (HF) with reduced ejection fraction.
• Individual variations in arterial load and HF therapy responses necessitate personalized treatment approaches.
• Understanding arterial afterload can optimize vasoactive medication for HF patients.

Purpose of the Study:

• To investigate the relationship between central aortic waveform characteristics and functional improvement in HF patients undergoing vasodilator therapy.
• To determine if advanced arterial analysis can predict treatment response more effectively than conventional methods.

Main Methods:

• Subjects with HF and reduced ejection fraction received aggressive vasodilator titration.
• Central aortic waveforms were analyzed using pulse wave, wave separation, and arterial reservoir models.
• Functional response was assessed via the 6-minute walk test.

Main Results:

• Patients showing functional improvement had higher baseline aortic pressure wave pulsatility (central pulse pressure, reflected pressure, reservoir pressure) compared to those without improvement (P<0.05).
• Aortic pressure pulsatility significantly decreased in subjects with functional improvement, but not in others (P for interaction <0.05).
• These arterial load differences were not detectable with standard brachial cuff pressures.

Conclusions:

• Increased aortic pressure wave pulsatility and its reduction during treatment are linked to functional gains in HF patients on vasodilators.
• Central aortic waveform analysis provides insights into treatment response not available through brachial cuff measurements.
• This advanced analysis may facilitate personalized vasoactive therapy for chronic HF with reduced ejection fraction.